Filing Details
- Accession Number:
- 0000874015-24-000197
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2024-09-04 21:06:29
- Reporting Period:
- 2024-02-02
- Accepted Time:
- 2024-09-04 21:06:29
- Original Submission Date:
- 2024-02-02
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 874015 | Ionis Pharmaceuticals Inc | IONS | Pharmaceutical Preparations (2834) | 330336973 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1838539 | Eugene Schneider | C/O Ionis Pharmaceuticals 2855 Gazelle Ct Carlsbad CA 92010 | Evp, Chf Clinical Develop Ofcr | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2024-02-02 | 2,106 | $49.59 | 47,659 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The original Form 4 filed on February 2, 2024 reported 2,071 restricted stock units sold by the reporting person which has been revised by this amendment to reflectthe actual amount of shares sold and beneficially owned by Mr. Schneider.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.58 to $49.60 inclusive. Thereporting person undertakes to provide to Ionis Pharmaceuticals, Inc. any security holder of Ionis Pharmaceuticals, Inc. or the staff of the Securities and ExchangeCommission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) on this Form 4.
Billionaire Hedge Funds
